-
British Medical Journal May 1950
Topics: Encephalitis, Viral; Meningitis, Viral; Meningoencephalitis; Mumps; Parotitis
PubMed: 15414357
DOI: 10.1136/bmj.1.4661.1052-a -
New South Wales Public Health Bulletin 2007
Topics: Disease Notification; Humans; Incidence; Measles-Mumps-Rubella Vaccine; Mumps; New South Wales; Public Health Administration
PubMed: 17985483
DOI: 10.1071/nb07091 -
British Medical Journal Dec 1961
Topics: Arthritis; Arthritis, Infectious; Humans; Mumps
PubMed: 14462617
DOI: 10.1136/bmj.2.5267.1613 -
British Medical Journal Feb 1956
Topics: Amylases; Blood; Clinical Enzyme Tests; Glycoside Hydrolases; Humans; Mumps; Pancreatitis
PubMed: 13284323
DOI: No ID Found -
BMJ (Clinical Research Ed.) May 2005
Review
Topics: Adult; Clinical Laboratory Techniques; Diagnosis, Differential; Disease Outbreaks; Female; Humans; Immunocompromised Host; Incidence; Measles-Mumps-Rubella Vaccine; Mumps; Pregnancy; Pregnancy Complications, Infectious; United Kingdom; Vaccination
PubMed: 15891229
DOI: 10.1136/bmj.330.7500.1132 -
Clinical Infectious Diseases : An... Aug 2018
Topics: Humans; Influenza, Human; Orthomyxoviridae; Parotitis; Seasons; United States
PubMed: 29617960
DOI: 10.1093/cid/ciy140 -
Otolaryngologic Clinics of North America Oct 1999Acute infection can involve any salivary gland, but it predominately affects the major salivary glands, especially the parotid gland. The anatomic and physiologic... (Review)
Review
Acute infection can involve any salivary gland, but it predominately affects the major salivary glands, especially the parotid gland. The anatomic and physiologic factors accounting for the parotid gland's predilection for infection are reviewed. Numerous conditions that are predisposed to acute bacterial sialadenitis and differ from risk factors associated with viral infection are also reviewed. The pathogenesis, diagnostic evaluation, treatment, complications, and prognosis of bacterial infections are discussed and contrasted with those of viral infections.
Topics: Acute Disease; Bacterial Infections; Combined Modality Therapy; Humans; Mumps; Penicillins; Risk Factors; Sialadenitis; Tomography, X-Ray Computed
PubMed: 10477787
DOI: 10.1016/s0030-6665(05)70173-0 -
Przeglad Epidemiologiczny 2018Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only...
BACKGROUND
Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only recommended. Despite observed decline in mumps incidence for over a decade which is a result of conducted vaccinations, mumps is still a common disease among the children.
AIM
To assess epidemiological situation of mumps in Poland in 2016, including vaccination coverage in Polish population, in comparison to previous years.
METHODS
The descriptive analysis was based on data retrieved from routine mandatory surveillance system and published in the annual bulletins “Infectious diseases and poisonings in Poland in 2016” and “Vaccinations in Poland in 2016”.
RESULTS
In total, there were 1 978 mumps cases registered in Poland in 2016. Incidence of mumps was 5.1 per 100,000 and it was lower in comparison with 2015. The highest incidence (7.0 per 100 000) was registered in Opolskie voivodeship and the lowest (2.9) – in Podkarpackie voivodeship. The highest incidence rate was observed among children aged 5 years (46.9 per 100 000). Incidence in men (6.2 per 100 000) was higher than in women (4.1). In 2016, 37 people were hospitalized due to mumps. Vaccination coverage of children aged 3 years in Poland in 2016 was 96,0% and it was lower by 0.3% in comparison with year 2015.
CONCLUSIONS
Systematic execution of mumps vaccination in accordance with the National Immunisation Programme resulted in a significant decrease in the number of registered cases. Due to the high vaccination coverage further decline in the number of cases is expected.
Topics: Adolescent; Adult; Age Distribution; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Mumps; Poland; Registries; Rural Population; Urban Population; Vaccination; Young Adult
PubMed: 30394050
DOI: 10.32394/pe.72.3.4 -
Euro Surveillance : Bulletin Europeen... Aug 2013In Germany, mumps has been notifiable until 2013 only in the five Eastern federal states (EFS) of former East Germany. Due to different immunisation policies until 1990...
In Germany, mumps has been notifiable until 2013 only in the five Eastern federal states (EFS) of former East Germany. Due to different immunisation policies until 1990 and varying vaccination coverages thereafter, mumps incidences cannot be extrapolated to the 11 Western federal states (WFS). We studied mumps-related International Classification of Diseases (ICD-10) code diagnoses claimed through statutory health insurances between 2007 and 2011 to estimate countrywide mumps incidences in the outpatient sector, and compared them with case numbers from ambulatory notification data. Overall, 32,330 outpatient mumps cases were claimed. Annual incidence ranged between 9.3/100,000 and 11.8/100,000 and showed a significant decreasing trend. Compared with EFS, mumps incidence in WFS was higher and indicated a shift towards older age groups. Notified outpatient case numbers in EFS were 13-fold lower and from voluntary surveillance during an outbreak in the WFS Bavaria 8-fold lower than from insurance data (n=316 versus n=4,217 and n=238 versus 1,995, respectively). Of all notified cases with available information, 75.4% (EFS) and 57.6% (Bavaria) were unvaccinated; 6.8% (EFS) and 19.3% (Bavaria) required hospitalisation. In Germany, mumps is still endemic despite decades of vaccination, with considerable underreporting in the established notification systems.
Topics: Adolescent; Adult; Age Distribution; Child; Disease Outbreaks; Female; Germany; Health Surveys; Humans; Immunization; Incidence; Male; Mandatory Reporting; Middle Aged; Mumps; Orchitis; Vaccination; Young Adult
PubMed: 23968877
DOI: 10.2807/1560-7917.es2013.18.33.20557 -
Anales de Pediatria Oct 2021Juvenile recurrent chronic parotitis (JRCP) is a rare disease of unknown cause. There is a growing interest in its autoimmune aetiology and its relationship with...
INTRODUCTION
Juvenile recurrent chronic parotitis (JRCP) is a rare disease of unknown cause. There is a growing interest in its autoimmune aetiology and its relationship with dysfunctions of cellular and humoral immunity, although there is no agreed protocol for complementary investigations for its study. A consecutive series of cases is presented where the immune alterations and associated autoimmune disorders are investigated, proposing a study algorithm.
PATIENTS AND METHODS
A retrospective study was carried out on patients who had JRCP during the period from 2013 to 2016 and a follow-up of at least 2 years. After its clinical and ultrasound diagnosis, complementary examinations were systematically carried out to investigate infectious, immune, and autoimmune diseases.
RESULTS
Of a total of 36 patients with inclusion criteria, 16 (44%) were found with some analytical alteration of a non-specific immunological nature (positive ANA, high IgG, low complement factor 4), or associated with a specific diagnosis, as occurred in 11 patients: Selective IgA deficiency (2), Sjögren's syndrome associated or not with systemic lupus erythematosus (3), coeliac disease associated or not with diabetes mellitus (4), Hashimoto's thyroiditis (1), and acquired immunodeficiency syndrome (1).
CONCLUSION
Juvenile recurrent chronic parotitis can be considered a sentinel sign of other diseases of immunological/autoimmune aetiology for which the diagnosis, monitoring and early treatment can improve its prognosis. Viral infectious aetiology, with the exception of HIV, is not a priority in the study of recurrences.
Topics: Autoimmune Diseases; Humans; Parotitis; Retrospective Studies; Sjogren's Syndrome; Ultrasonography
PubMed: 34518129
DOI: 10.1016/j.anpede.2020.08.012